An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)
Condition: NAFLD Interventions: Drug: Saroglitazar; Drug: Vitamin E; Drug: Combination drug; Behavioral: Lifestyle Changes Sponsor: Asian Institute of Gastroenterology, India Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alcoholism | Fatty Liver Disease (FLD) | Gastroenterology | India Health | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Research | Study | Urology & Nephrology | Vitamin E | Vitamins